Placenta Injection
qd placenta injection
Placenta injection is the common name for injections of Hominis Placenta extract or hydrolysate, obtained from human placenta. In Korea, depending on the product, it is approved for “improvement of liver function in chronic liver disease” or “improvement of menopausal symptoms”. Because it is derived from human placenta, the approved product information warns that the risk of transmitting infection cannot be completely ruled out — QD Clinic explains this first.
Placenta Injection is available at QD Clinic in Gangnam, Seoul, Korea.
is this for me
Who it’s for
Even if none of these describes you, we will look again at the consultation.
- You want to confirm the ingredient and approved indications of placenta injection
- You are concerned that it is human-derived and want to hear about the risks first
- You would like a consultation about menopausal symptoms
If you have menopausal symptoms or liver disease, the standard treatment for that condition comes before placenta injection. Please don’t change any treatment you are receiving on your own.
start with your concern
Before you pick a treatment name, start with the cause of your concern.
Even a treatment with the same name takes on a different role and scope depending on your current structure, the change you want, what you have had before and the recovery time you have.
Where you are now, and where we start
Approved indications of human-placenta-derived ingredients, and disclosure of the risk of infection transmission
The change you want, the impression you keep
We check which of the two approved indications your goal falls under, or whether it lies outside them.
How it differs from similar options
We explain the label warning that the risk of infection transmission from a human-placenta-derived ingredient cannot be completely ruled out.
Health information and recovery schedule
The approved routes are subcutaneous and intramuscular injection, so we tell you in advance which product and route we use.
the principle
How it works
Placenta injection is derived from human placenta and has two approved indications.
According to the MFDS drug database (nedrug), Hominis Placenta hydrolysate injection is approved for “improvement of liver function in chronic liver disease”, and Hominis Placenta extract injection for “improvement of menopausal symptoms”. For both, the source placenta is tested at collection and processed during manufacture, but because the risk of transmitting infection cannot be completely ruled out, the label says to use only the minimum amount necessary.
How it works
Ingredient
Hominis Placenta extract or hydrolysate — that is, ingredients obtained from human placenta. A 2018 MFDS document refers to it as “a.k.a. placenta injection”.
Approved use by product
Hydrolysate products: improving liver function in chronic liver disease. Extract products: improving menopausal symptoms.
Approved routes
Hydrolysate products are approved for subcutaneous or intramuscular injection; extract products for subcutaneous injection (2mL per dose, 3 times a week for 2 weeks).
Infection-transmission warning
Despite testing of the source material and processing during manufacture, the risk of transmitting infection cannot be completely ruled out, so only the minimum necessary amount is to be used.
the qd standard
The same treatment, never the same plan.
Rather than a fashionable name or a fixed package, we weigh the structure found at examination, safety, recovery and the limits within one plan.
- DIAGNOSIS FIRST
Cause before name
We first separate out the tissue and the function behind your concern.
- LESS, PRECISE
Only as much as needed
Rather than an excessive change, we plan the smallest scope with a clear role.
- HONEST LIMIT
The limits, explained too
We explain the change you can expect, the alternatives, individual differences and the risks.
personal plan
From consultation to follow-up, planned as one flow.
Placenta injection is the common name for injections of Hominis Placenta extract or hydrolysate, obtained from human placenta. In Korea, depending on the product, it is approved for “improvement of liver function in chronic liver disease” or “improvement of menopausal symptoms”. Because it is derived from human placenta, the approved product information warns that the risk of transmitting infection cannot be completely ruled out — QD Clinic explains this first.
Goal vs approved use
We check whether your goal falls under improving liver function or menopausal symptoms.
Explaining the risks
We first explain the possibility of infection transmission from a human-derived ingredient, and the possibility of shock or hypersensitivity.
Product and route
We explain the approved method (subcutaneous or intramuscular) for the product we actually use, and check your reaction afterwards.
What the procedure is like
- Medical history — allergic tendency, existing conditions
- Explanation of the infection-transmission risk and approved indications
- Injection by the approved route
- Check of the injection site and whole-body reactions
The injection itself is quick, but time is needed afterwards to watch for any reaction.
Please read this before treatment
- The injection site may swell or harden. Please don’t rub it.
- If you get chills or a fever, contact the clinic.
- If you notice a breast lump or pain, tell us before your next session.
Safety & considerations
Contraindications and cautions in the label
- Hypersensitivity to the ingredient
- Use with caution in people prone to allergies
- Hominis Placenta extract products: newborns, premature infants, etc. (contains benzyl alcohol)
Adverse reactions in the label
- Possibility of shock
- Chills, fever, rash
- Pain, redness or hardening at the injection site
- Breast enlargement (gynecomastia)
Placenta injection is not a medicine approved for cosmetic use or fatigue relief, and the risk of infection transmission from its human-placenta-derived ingredient cannot be completely ruled out. Individual responses vary.
what to expect
What to expect over time
A general guide to how the days and months after treatment usually unfold. Results vary by individual.
Right after
Possibility of shock
The label states that, as a protein and amino-acid preparation derived from human tissue, the possibility of shock cannot be ruled out.
On the day
Injection site
Pain, redness or hardening may occasionally occur.
Afterwards
Uncommon reactions
Chills, fever and rash, and occasionally breast enlargement (gynecomastia), are listed. If you notice these changes, we stop and talk it through.
Sessions & results
Our treatment menu has a single session and 5 sessions. Because the label says to use “only the minimum amount necessary”, we recheck the need each time, even if you chose the 5-session option.
how it compares
How it compares
Placenta injection sits with the other drips on our treatment menu, but its ingredient source and approved route are different.
| Placenta Injection | Licorice Injection | Glutathione Injection (White Jade) | |
|---|---|---|---|
| Ingredient source | Human placenta | Licorice-derived glycyrrhizic acid + glycine + cysteine | Reduced glutathione |
| Approved route | Subcutaneous or intramuscular (by product) | IV injection or IV drip | Intramuscular or intravenous |
| Special warning in the label | Risk of infection transmission cannot be completely ruled out | Pseudoaldosteronism with higher doses or long-term use | Rare anaphylaxis-like symptoms |
Based on Korean-approved products with the same ingredient.
before consultation
Before you decide, the questions people always ask
Yes. The active ingredient is Hominis Placenta extract or hydrolysate, and Hominis Placenta means human placenta. The product information also states that it “uses human placenta as its raw material”.
The label states that the source material is tested at collection and processed during manufacture, but the risk of transmitting infection cannot be completely ruled out. That is why only the minimum necessary amount is to be used. QD Clinic explains this risk before any injection, and you decide whether to go ahead once you have heard it.
Both are called placenta injections, but their approvals differ. Laennec (Hominis Placenta hydrolysate) is approved for improving liver function in chronic liver disease, and Melsmon (Hominis Placenta extract) for improving menopausal symptoms. Their routes and dosing schedules also differ.
The approved method for Korean-approved products is subcutaneous or intramuscular injection. Intravenous use is not part of the approved method. We will confirm the product we use and how it is given at your consultation.
Breast enlargement (gynecomastia) and breast pain are listed as adverse reactions in the product information. If you feel a lump in the breast or notice pain, be sure to tell us before your next injection. When such changes appear, the injections should be stopped and discussed with the medical team.
Related treatments
Anti-AgingFacial Stem Cell (NovaStem)
qd facial stem cellGrowth factors released by cells, used on facial skin. We first check what is injected, where it comes from and how it is prepared.
Anti-AgingFull-body Stem Cell (NovaStem)
qd full-body stem cellThe same approach, applied over wider areas of the body. We look at the evidence for what is infused and the whole-body risks.
Anti-AgingChanel Injection (NCTF)
qd chanel injectionAn NCTF solution, delivered in many micro-injections. Not a filler that adds volume — it works on the condition of the skin.
personal consultation
Tell us what bothers you now, the change you want, what you have had done before and any dates that matter. We will compare the possible approaches and their limits, calmly.
Consult now